Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Apyx Medical Corporation
APYX | US
1.17
USD-0.01
-1.15%
APYX | US
About Apyx Medical Corporation
Sector
Healthcare
Industry
Medical Instruments & Supplies
Earnings date
30/06/2024
As of date
21/10/2024
Close
1.17
Open
1.17
High
1.20
Low
1.16
Apyx Medical Corporation an energy technology company develops manufactures and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater Florida.
View LessAPYX | US
Risk
55.3
Sharpe
-0.58
Luna's Score
27/100
Recommendation
Sell
Luna says (APYX | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
37.2%1 month
55.3%3 months
78.9%6 months
75.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.80
Debt to equity
2.62
Debt to assets
0.59
Ent. to EBITDA
-5.33
Ent. to rev.
0.96
PEG
-
Other Fundamentals
EBITDA
-21.67M
MarketCap
40.53M
MarketCap(USD)
40.53M
Div. yield
-
Op. margin
-45.66
Erngs. growth
-
Rev. growth
-10.50
Ret. on equity
-110.25
Short ratio
6.32
Short perc.
0.73
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.19
Range1M
0.23
Range3M
0.49
Volumes: Market Activity
Rel. volume
1.11
Price X volume
40.41K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.33 | 4.19 | Cheaper |
| Ent. to Revenue | 0.96 | 8.10 | Cheaper |
| PE Ratio | - | 47.18 | - |
| Price to Book | 2.80 | 5.71 | Cheaper |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 78.90 | 56.96 | Riskier |
| Debt to Equity | 2.62 | 0.92 | Expensive |
| Debt to Assets | 0.59 | 0.27 | Expensive |
| Market Cap | 40.53M | 10.37B | Emerging |
